Sarepta Therapeutics, Inc. Uncategorized Contracts & Agreements

56 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Supplement to JPMorgan Chase Bank, National Association Base Capped Call Option Transaction Confirmation and Additional Capped Call Option Transaction Confirmation
Sarepta Therapeutics, Inc.
Biotechnology
NY
2024
Supplement to Goldman Sachs & Co. LLC Base Capped Call Option Transaction Confirmation and Additional Capped Call Option Transaction Confirmation
Sarepta Therapeutics, Inc.
Biotechnology
2024
Additional Call Option Transaction Confirmation, dated as of September 14, 2022 between Sarepta Therapeutics, Inc. and RBC Capital markets, LLC
Sarepta Therapeutics, Inc.
Biotechnology
2022
Additional Call Option Transaction Confirmation, dated as of September 14, 2022 between Sarepta Therapeutics, Inc. and Morgan Stanley & Co. LLC
Sarepta Therapeutics, Inc.
Biotechnology
2022
Additional Call Option Transaction Confirmation, dated as of September 14, 2022 between Sarepta Therapeutics, Inc. and Mizuho Markets Americas LLC
Sarepta Therapeutics, Inc.
Biotechnology
2022
Additional Call Option Transaction Confirmation, dated as of September 14, 2022 between Sarepta Therapeutics, Inc. and Goldman Sachs & Co. LLC
Sarepta Therapeutics, Inc.
Biotechnology
2022
Additional Call Option Transaction Confirmation, dated as of September 14, 2022 between Sarepta Therapeutics, Inc. and Barclays Bank PLC
Sarepta Therapeutics, Inc.
Biotechnology
2022
Base Call Option Transaction Confirmation, dated as of September 13, 2022, between Sarepta Therapeutics, Inc. and RBC Capital Markets, LLC
Sarepta Therapeutics, Inc.
Biotechnology
2022
Base Call Option Transaction Confirmation, dated as of September 13, 2022, between Sarepta Therapeutics, Inc. and Morgan Stanley & Co. LLC
Sarepta Therapeutics, Inc.
Biotechnology
2022
Base Call Option Transaction Confirmation, dated as of September 13, 2022, between Sarepta Therapeutics, Inc. and Mizuho Markets Americas LLC
Sarepta Therapeutics, Inc.
Biotechnology
2022
Base Call Option Transaction Confirmation, dated as of September 13, 2022, between Sarepta Therapeutics, Inc. and Goldman Sachs & Co. LLC
Sarepta Therapeutics, Inc.
Biotechnology
2022
Base Call Option Transaction Confirmation, dated as of September 13, 2022, between Sarepta Therapeutics, Inc. and Barclays Bank PLC
Sarepta Therapeutics, Inc.
Biotechnology
2022
Letter Agreement, dated April 19, 2022, between Sarepta Therapeutics, Inc. and Douglas S. Ingram
Sarepta Therapeutics, Inc.
Biotechnology
2022
Offer Letter dated March 17, 2017 by and between Sarepta Therapeutics, Inc. and Joseph Bratica
Sarepta Therapeutics, Inc.
Biotechnology
2021
Offer Letter dated by December 18, 2014 and between Sarepta Therapeutics, Inc. and Ian M. Estepan
Sarepta Therapeutics, Inc.
Biotechnology
2021
Promotion Letter dated December 14, 2020 by and between Sarepta Therapeutics, Inc. and Ian M. Estepan
Sarepta Therapeutics, Inc.
Biotechnology
2021
Offer Letter dated April 19, 2018 by and between Sarepta Therapeutics, Inc. and Louise Rodino-Klapac
Sarepta Therapeutics, Inc.
Biotechnology
2021
Promotion Letter dated December 14, 2020 by and between Sarepta Therapeutics, Inc. and Louise Rodino-Klapac
Sarepta Therapeutics, Inc.
Biotechnology
2021
Description of Registered Securities
Sarepta Therapeutics, Inc.
Biotechnology
2020
Letter Agreement between Sarepta Therapeutics, Inc. and Myonexus Therapeutics, Inc. dated February 26, 2019
Sarepta Therapeutics, Inc.
Biotechnology
2019
Letter Agreement between Douglas S. Ingram and Sarepta Therapeutics, Inc. dated June 26, 2018
Sarepta Therapeutics, Inc.
Biotechnology
MA
2018
First Amendment to Sponsored Research Agreement between AVI BioPharma, Inc. and Charleys Fund, Inc. dated June 2, 2009
Sarepta Therapeutics, Inc.
Biotechnology
2018
Sponsored Research Agreement between AVI BioPharma, Inc. and Charleys Fund, Inc., effective October 12, 2007
Sarepta Therapeutics, Inc.
Biotechnology
OR
2018
Additional Call Option Transaction Confirmation, dated as of November 9, 2017, between Sarepta Therapeutics, Inc. and Goldman Sachs & Co. LLC
Sarepta Therapeutics, Inc.
Biotechnology
2017
Additional Call Option Transaction Confirmation, dated as of November 9, 2017, between Sarepta Therapeutics, Inc. and JPMorgan Chase Bank, National Association, London Branch
Sarepta Therapeutics, Inc.
Biotechnology
OH
2017
Base Call Option Transaction Confirmation, dated as of November 8, 2017, between Sarepta Therapeutics, Inc. and Goldman Sachs & Co. LLC
Sarepta Therapeutics, Inc.
Biotechnology
2017
Base Call Option Transaction Confirmation, dated as of November 8, 2017, between Sarepta Therapeutics, Inc. and JPMorgan Chase Bank, National Association, London Branch
Sarepta Therapeutics, Inc.
Biotechnology
OH
2017
Letter Agreement by and between Sarepta Therapeutics, Inc. and Catherine Stehman-Breen dated September 26, 2017
Sarepta Therapeutics, Inc.
Biotechnology
MA
2017
Letter Agreement by and between Sarepta Therapeutics, Inc. and Guriqbal S. Basi dated September 25, 2017
Sarepta Therapeutics, Inc.
Biotechnology
MA
2017
Offer Letter dated August 28, 2017 by and between Sarepta Therapeutics, Inc. and Guriqbal S. Basi
Sarepta Therapeutics, Inc.
Biotechnology
2017
Offer Letter dated February 2, 2017 by and between Sarepta Therapeutics, Inc. and Dr. Catherine Stehman-Breen
Sarepta Therapeutics, Inc.
Biotechnology
2017
Offer Letter dated December 3, 2012 by and between Sarepta Therapeutics, Inc. and Alexander Bo Cumbo
Sarepta Therapeutics, Inc.
Biotechnology
2017
Offer Letter dated December 5, 2012 by and between Sarepta Therapeutics, Inc. and Shamim Ruff
Sarepta Therapeutics, Inc.
Biotechnology
2017
[**] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission.
Sarepta Therapeutics, Inc.
Biotechnology
2016
15B, SUPPLIES/SERVICES
Sarepta Therapeutics, Inc.
Biotechnology
2012
3. EFFECTIVE DATE 13-Apr-2011
Sarepta Therapeutics, Inc.
Biotechnology
2011
11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS
Sarepta Therapeutics, Inc.
Biotechnology
2011
3450 MonteVilla Parkway, Suite 101, Bothell, WA 98021 ** 425 ###-###-#### ** FAX: 425 ###-###-####
Sarepta Therapeutics, Inc.
Biotechnology
2011
AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT
Sarepta Therapeutics, Inc.
Biotechnology
2010
SETTLEMENTAGREEMENT
Sarepta Therapeutics, Inc.
Biotechnology
WA
2010